HoPE (Hospice Preparation and Education)

NCT04410627 | Withdrawn DMC

• 1 other identifier: Pro00105058
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 2

Brief Summary

The investigator will conduct a two-site, randomized, controlled study of the HoPE (Hospice Preparation and Education) web-based tool versus usual care to assess: Technology usability (primary), study feasibility (secondary), user acceptability (secondary), and hospice service conversion rate (exploratory). Technology usability will be assessed through a one-time quantitative survey using established instruments. Study feasibility and user accessibility will be assessed through trial enrollment and retention alongside analytics assessing tool usage (e.g. time spent on each page of the website). Conversion rate is the percent of patients introduced to hospice who eventually enroll. The investigators will evaluate in an exploratory manner the differential effect of HoPE versus usual care.

Conditions

Hospice Care

Outcome Measures

Primary Outcomes (1)

• Technology usability as measured by System Usability Scale

  To determine usability, the System Usability Scale will be administered to each participant in the intervention arm. As described by usability.gov: "The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking. Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average, however the best way to interpret your results involves "normalizing" the scores to produce a percentile ranking."

  At study completion, up to 4 months.

Secondary Outcomes (3)

• Study Feasibility as measured by enrollment efficiency

  At study completion, up to 4 months

• Study Feasibility as measured by intervention completion

  At study completion, up to 4 months

• User Accessibility as measured by Net Promoter score

  At study completion, up to 4 months

Study Arms (2)

Standard of Care

NO INTERVENTION

Standard of Care + HoPE

EXPERIMENTAL

Other: HoPE Website

Interventions

HoPE Website OTHER

Educational website focused on hospice care

Standard of Care + HoPE

Eligibility Criteria

• Age: 21 Years - 89 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Eligible for and referral made for home hospice services (Note: this excludes home palliative care, home infusion, home nursing, home physical therapy, and bridge services)
• Aged between 21 and 89
• Capacity to give consent
• Ability to speak and understand English

Sponsors & Collaborators

• Duke University: lead

Study Sites (2)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

WakeMed Health & Hospitals

Raleigh, North Carolina, 27610, United States

Location

Study Officials

• Arif Kamal, MD

  Duke University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 26, 2020
• First Posted: June 1, 2020
• Study Start: June 1, 2022
• Primary Completion: December 31, 2022
• Study Completion: December 31, 2022
• Last Updated: March 18, 2022

Record last verified: 2022-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (2)